49 episodes

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

First Rounders Nature Biotechnology

    • Natural Sciences

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

    Noubar Afeyan

    Noubar Afeyan

    Noubar Afeyan is the founder and CEO of Flagship Pioneering. His conversation with Nature Biotechnology covers his family fleeing the Lebanese Civil War when he was a boy, how a chance encounter at a scientific meeting opened his mind to entrepreneurism, and why immigrants (and entrepreneurs) benefit from having a “paranoid optimist” mindset. 
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 7 min
    Katrine Bosley

    Katrine Bosley

    Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 8 min
    Ted Love

    Ted Love

    Ted Love is the president and CEO of Global Blood Therapeutics. In his conversation with Nature Biotechnology, he discusses why his time at Haverford College was transformative, why he views Global Blood Therapeutics as a social justice company, and what might be gained from the “racial catharsis” happening in America after the police killing of George Floyd.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 22 min
    Alexis Borisy

    Alexis Borisy

    Alexis Borisy is CEO and Chairman of EQRx, and a long-time biotech builder with Third Rock Ventures. His conversation with Nature Biotechnology covers growing up as a “faculty brat” in Wisconsin, dropping out of his PhD program at Harvard and why, even as an investor, biotech cannot be all about the money. 
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 5 min
    Bonus: Jeremy Levin

    Bonus: Jeremy Levin

    A conversation with Jeremy Levin, chairman of the Biotechnology Innovation Organization and CEO of Ovid Therapeutics, about industry versus government responses to covid19, the split within biotech on how to address charges of high prices, and why the biopharma industry is so disliked. 
     
    See acast.com/privacy for privacy and opt-out information.

    • 46 min
    Bassil Dahiyat

    Bassil Dahiyat

    Bassil Dahiyat is co-founder, president and CEO of Xencor. His conversation with Nature Biotechnology covers his parents emigrating from Jordan, how Xencor has survived (and changed) over the past 22 years, and when it’s necessary for a CEO to speak out.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 3 min

Top Podcasts In Natural Sciences

Listeners Also Subscribed To